Search results
Results from the WOW.Com Content Network
Henrietta Lacks (born Loretta Pleasant; August 1, 1920 – October 4, 1951) [2] was an African-American woman [5] whose cancer cells are the source of the HeLa cell line, the first immortalized human cell line [B] and one of the most important cell lines in medical research.
Henrietta Lacks’ descendants joined the groundbreaking at the future site of the Baltimore building. ... the 31-year-old mother of five was diagnosed with cervical cancer. Despite treatment, she ...
In 1951, Henrietta Lacks was admitted to the Johns Hopkins Hospital with symptoms of irregular vaginal bleeding; she was subsequently treated for cervical cancer. [9] Her first treatment was performed by Lawrence Wharton Jr., who at that time collected tissue samples from her cervix without her consent. [10]
Advocates, congressional leaders and the family of Henrietta Lacks say she deserves to be honored for her unknowing contribution to medicine that has played a vital role in the polio vaccine ...
Henrietta Lacks (born Loretta Pleasant; August 1, 1920 – October 4, 1951) was an African-American woman whose cancer cells are the source of the HeLa cell line, the first immortalized human cell line and one of the most important cell lines in medical research. An immortalized cell line reproduces indefinitely under specific conditions, and ...
The family of Henrietta Lacks has settled a lawsuit over the use of her endlessly reproducing cells, which changed modern medicine and saved millions of lives. Lacks’ surviving family members ...
The Immortal Life of Henrietta Lacks is a 2017 American drama television film directed by George C. Wolfe and starring Oprah Winfrey and Rose Byrne.It is based on the book of the same name by Rebecca Skloot and documents the story of Henrietta Lacks, who was diagnosed with cervical cancer in the 1950s, and whose cancer cells (later known as HeLa) would change the course of cancer treatment.
In their complaint, Lacks’ grandchildren and other descendants argued that her treatment illustrates a much larger issue that persists today: The post Biotech firm settles with family of ...